We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

93 hedge funds and large institutions have $568M invested in Dyne Therapeutics in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 5

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

65% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 20

23.98% more ownership

Funds ownership: 68.77% → 92.75% (+24%)

12% more funds holding

Funds holding: 83 → 93 (+10)

1% less capital invested

Capital invested by funds: $573M → $568M (-$4.73M)

Holders
93
Holders Change
+10
Holders Change %
+12.05%
% of All Funds
1.43%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
17
Increased
33
Reduced
20
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.01M
2
BlackRock
BlackRock
New York
+$5.95M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$5.09M
4
Marshall Wace
Marshall Wace
United Kingdom
+$4.6M
5
WP
Woodline Partners
California
+$4.19M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$10.3M
2
LGM
Logos Global Management
California
-$5.41M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$4.07M
4
SFM
Sphera Funds Management
Israel
-$1.68M
5
SG Americas Securities
SG Americas Securities
New York
-$1.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$4.15M +$4.6M +327,227 +1,484%
SCM
27
Soleus Capital Management
Connecticut
$4.03M +$2.25M +160,400 +90%
CS
28
Candriam SCA
Luxembourg
$3.85M – – –
CC
29
Commodore Capital
New York
$3.63M – – –
Northern Trust
30
Northern Trust
Illinois
$3.11M +$56.5K +4,023 +2%
EC
31
EcoR1 Capital
California
$2.56M – – –
Charles Schwab
32
Charles Schwab
California
$2.24M +$61.5K +4,376 +2%
ACH
33
ArrowMark Colorado Holdings
Colorado
$2M – – –
ACM
34
Altium Capital Management
New York
$1.98M – – –
N
35
Nuveen
North Carolina
$1.66M -$82K -5,835 -4%
Two Sigma Investments
36
Two Sigma Investments
New York
$1.52M +$204K +14,525 +13%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.38M -$4.07M -289,315 -71%
HMC
38
Harvard Management Company
Massachusetts
$1.27M – – –
SFM
39
Sphera Funds Management
Israel
$1.25M -$1.68M -119,879 -53%
Adage Capital Partners
40
Adage Capital Partners
Massachusetts
$1.19M +$703K +50,000 +100%
MIM
41
Monashee Investment Management
Massachusetts
$1.13M +$1.34M +95,300 New
Goldman Sachs
42
Goldman Sachs
New York
$1.01M +$637K +45,349 +115%
Renaissance Technologies
43
Renaissance Technologies
New York
$814K -$1.01M -72,000 -51%
Bank of America
44
Bank of America
North Carolina
$762K +$713K +50,716 +381%
Swiss National Bank
45
Swiss National Bank
Switzerland
$606K – – –
Two Sigma Advisers
46
Two Sigma Advisers
New York
$593K +$316K +22,500 +82%
First Trust Advisors
47
First Trust Advisors
Illinois
$477K +$72.1K +5,128 +15%
Ensign Peak Advisors
48
Ensign Peak Advisors
Utah
$476K – – –
Tudor Investment Corp
49
Tudor Investment Corp
Connecticut
$465K +$550K +39,115 New
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$463K – – –
1
2
3 4

DYN Hedge Fund Activity: Q4 2021 in Review

93 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q4 2021, worth a combined $568M — down 0.83% from $573M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new DYN positions and 5 closed out — a net gain of 12 holders — while 33 added to existing stakes and 20 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $6.01M. The largest seller was Wellington Management Group, cutting an estimated $10.3M.

  • 93 institutional investors held Dyne Therapeutics (DYN) as of Q4 2021, up from 83 in Q3 2021.
  • Funds reported $568M of Dyne Therapeutics stock for Q4 2021, down 0.83% quarter-over-quarter.
  • 17 funds opened new Dyne Therapeutics positions in Q4 2021 and 5 closed out, a net change of +12 holders.
  • The largest Dyne Therapeutics buyer in Q4 2021 was Point72 Asset Management, an estimated $6.01M added.
  • The largest Dyne Therapeutics seller in Q4 2021 was Wellington Management Group, an estimated $10.3M sold.

Based on aggregated 13F filings for Q4 2021.